General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2021       $ 43,400 $ (14,444) $ 28,956
Beginning Balances (in shares) at Dec. 31, 2021     35,886      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options       4   4
Exercise of stock options (in shares)     2      
Share issuance, net       5,195   5,195
Share issuance, net (in shares)     15,489      
Stock-based compensation       1,420   1,420
Stock-based compensation (in shares)     7,017      
Tax impact of equity transactions       2   2
Net loss         (30,112) (30,112)
Ending Balance at Dec. 31, 2022       50,021 (44,556) 5,465
Ending Balance (in shares) at Dec. 31, 2022     58,394      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share issuance, net       300   300
Share issuance, net (in shares)     2,778      
Stock-based compensation       (10)   (10)
Net loss         (3,144) (3,144)
Ending Balance at Mar. 31, 2023       50,311 (47,700) 2,611
Ending Balance (in shares) at Mar. 31, 2023     61,172      
Beginning Balances at Dec. 31, 2022       50,021 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     58,394      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (9,196)
Ending Balance at Jun. 30, 2023           1,564
Beginning Balances at Dec. 31, 2022       50,021 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     58,394      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (16,635)
Ending Balance at Sep. 30, 2023           (5,834)
Beginning Balances at Dec. 31, 2022       50,021 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     58,394      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of warrants (in shares)     41,667      
Share issuance, net       5,383   5,383
Share issuance, net (in shares)     227,315      
Share issuance, acquisition related       205   205
Share issuance, acquisition related (in shares)     30,441      
Stock-based compensation       (300)   (300)
Stock-based compensation (in shares)     14,921      
Tax impact of equity transactions       (10)   (10)
Net loss         (26,078) (26,078)
Fractional shares issued related to reverse split (shares)     620      
Ending Balance at Dec. 31, 2023       55,299 (70,634) (15,335)
Ending Balance (in shares) at Dec. 31, 2023     373,359      
Beginning Balances at Mar. 31, 2023       50,311 (47,700) 2,611
Beginning Balances (in shares) at Mar. 31, 2023     61,172      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (6,052)
Ending Balance at Jun. 30, 2023           1,564
Beginning Balances at Dec. 31, 2023       55,299 (70,634) (15,335)
Beginning Balances (in shares) at Dec. 31, 2023     373,359      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation       174   $ 174
Stock-based compensation (in shares)     14,931     14,931
Net loss         (3,761) $ (3,761)
Convertible debt converted into common shares       334   334
Convertible debt converted into common shares (in shares)     74,298      
Ending Balance at Mar. 31, 2024 $ (22) $ (22)   $ 55,807 $ (74,417) $ (18,610)
Ending Balance (in shares) at Mar. 31, 2024     462,588